GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lattice Biologics Ltd (OTCPK:LBLTF) » Definitions » Other Operating Expense

Lattice Biologics (Lattice Biologics) Other Operating Expense : $0.07 Mil (TTM As of Jun. 2021)


View and export this data going back to 2001. Start your Free Trial

What is Lattice Biologics Other Operating Expense?

Lattice Biologics's Other Operating Expense for the three months ended in Jun. 2021 was $0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2021 was $0.07 Mil.

Lattice Biologics's quarterly Other Operating Expense increased from Dec. 2020 ($0.02 Mil) to Mar. 2021 ($0.06 Mil) but then declined from Mar. 2021 ($0.06 Mil) to Jun. 2021 ($0.00 Mil).

Lattice Biologics's annual Other Operating Expense increased from Sep. 2018 ($0.15 Mil) to Sep. 2019 ($0.15 Mil) but then declined from Sep. 2019 ($0.15 Mil) to Sep. 2020 ($0.15 Mil).


Lattice Biologics Other Operating Expense Historical Data

The historical data trend for Lattice Biologics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lattice Biologics Other Operating Expense Chart

Lattice Biologics Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Sep16 Sep17 Sep18 Sep19 Sep20
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.15 0.15 0.15 0.15

Lattice Biologics Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 -0.01 0.02 0.06 -

Lattice Biologics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lattice Biologics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Lattice Biologics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Lattice Biologics (Lattice Biologics) Business Description

Traded in Other Exchanges
N/A
Address
512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714
Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.

Lattice Biologics (Lattice Biologics) Headlines

No Headlines